Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Pandemic Speeds Up Digital Transformation Plans as Enterprises Mount Responses to Rapid Changes: https://mms.businesswire.com/media/20210201005142/en/1016900/5/ISG_%28R%29_Logo.jpg
Pandemic Speeds Up Digital Transformation Plans as Enterprises Mount Responses to Rapid Changes


The COVID-19 pandemic has accelerated enterprise digital transformation by three to five years as companies build IT ecosystems to enable growth, innovation and improved customer experiences under

UBS Releases Statement Regarding Three Custom ETNs: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23977/300px-UBS_Logo_SVG.svg.png
UBS Releases Statement Regarding Three Custom ETNs


UBS AG announced today that it will not issue any new notes in three of its outstanding custom ETNs (the “Custom ETNs”), which are listed in Table-1 below. In addition, UBS AG will cap the maximum

Roku Announces Scott Rosenberg to Step Down as SVP and GM of Platform Business
Roku Announces Scott Rosenberg to Step Down as SVP and GM of Platform Business


Roku, Inc. (NASDAQ: ROKU) announced today that Scott Rosenberg, Senior Vice President and General Manager of Platform Business, plans to step down sometime in the spring of 2022. Rosenberg joined

AGCO Announces 2021 Fourth Quarter Earnings Release and Conference Call: https://mms.businesswire.com/media/20191202006003/en/760023/5/agco_logo_w_descriptor2C.jpg
AGCO Announces 2021 Fourth Quarter Earnings Release and Conference Call


AGCO, Your Agriculture Company, (NYSE: AGCO), a worldwide manufacturer and distributor of agricultural machinery and precision ag technology, announced today its 2021 Fourth Quarter Earnings

Tokens.com’s Subsidiary, Metaverse Group, Partners with Decentraland to Launch Start-Up Competition: https://mms.businesswire.com/media/20210525005244/en/880744/5/tokens-logo_%281%29_%282%29.jpg
Tokens.com’s Subsidiary, Metaverse Group, Partners with Decentraland to Launch Start-Up Competition


Tokens.com Corp. (NEO Exchange Canada: COIN) (Frankfurt Stock Exchange: 76M) (OTCQB US: SMURF) (“Tokens.com” or the “Company”), a publicly-traded company that invests in crypto assets linked to the

New Constellation Board of Directors Named: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24420/375px-Exelon_Corp_logo.png
New Constellation Board of Directors Named


Exelon Corp. (Nasdaq: EXC) today announced Constellation’s Board of Directors following the company’s separation from Exelon. The transaction, which has received all regulatory approvals and is

Form 8.3 - The Vanguard Group, Inc.: NortonLife Lock Inc.http://www.icatcher.com/wp-content/uploads/2012/04/Symantec.jpg: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/12176/Symantec.jpg
Form 8.3 - The Vanguard Group, Inc.: NortonLife Lock Inc.
Form 8.3 - The Vanguard Group, Inc.: NortonLife Lock Inc.
Lindsay Corporation Announces Quarterly Dividend
Lindsay Corporation Announces Quarterly Dividend


Lindsay Corporation (NYSE: LNN), a leading global manufacturer and distributor of irrigation and infrastructure equipment and technology, announced today that its Board of Directors has declared a

DGAP-Adhoc: ​​​​​​​PAION ASSIGNS CHINESE REMIMAZOLAM PATENTS AND SELLS RELATED FUTURE ROYALTIES FOR EUR 20.5 MILLION TO HUMANWELL HEALTHCARE GROUP: https://upload.wikimedia.org/wikipedia/de/thumb/4/45/Paion-logo.svg/640px-Paion-logo.svg.png
DGAP-Adhoc: ​​​​​​​PAION ASSIGNS CHINESE REMIMAZOLAM PATENTS AND SELLS RELATED FUTURE ROYALTIES FOR EUR 20.5 MILLION TO HUMANWELL HEALTHCARE GROUP
DGAP-Adhoc: ​​​​​​​PAION ASSIGNS CHINESE REMIMAZOLAM PATENTS AND SELLS RELATED FUTURE ROYALTIES FOR EUR 20.5 MILLION TO HUMANWELL HEALTHCARE GROUP
DGAP-Adhoc: Biotest AG: Grifols, S.A. will hold more than 95,5498 % of the voting rights upon settlement of the takeover offer: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24092/375px-Biotest_logo.svg.png
DGAP-Adhoc: Biotest AG: Grifols, S.A. will hold more than 95,5498 % of the voting rights upon settlement of the takeover offer
DGAP-Adhoc: Biotest AG: Grifols, S.A. will hold more than 95,5498 % of the voting rights upon settlement of the takeover offer
DGAP-News: Steinhoff International Holdings N.V. : SATISFACTION OF SUSPENSIVE CONDITIONS UNDER SIHPL NQC SETTLEMENTS: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23739/Steinhoff_Logo.svg.png
DGAP-News: Steinhoff International Holdings N.V. : SATISFACTION OF SUSPENSIVE CONDITIONS UNDER SIHPL NQC SETTLEMENTS
DGAP-News: Steinhoff International Holdings N.V. : SATISFACTION OF SUSPENSIVE CONDITIONS UNDER SIHPL NQC SETTLEMENTS
Nordic Enterprises Prove Digital Leadership With Transformations to Compete in Post-Pandemic World: https://mms.businesswire.com/media/20210201005142/en/1016900/5/ISG_%28R%29_Logo.jpg
Nordic Enterprises Prove Digital Leadership With Transformations to Compete in Post-Pandemic World


The COVID-19 pandemic has accelerated adoption of digital solutions in the Nordic region, which already led Europe in this area before the crisis, according to a new research report published today

argenx Highlights Strategic Priorities for 2022
argenx Highlights Strategic Priorities for 2022


Regulatory News:



argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced its strategic

NOXXON Provides Progress Update on the Expansion Arms of the Phase 1/2 GLORIA Trial With NOX-A12 in Brain Cancer Patients
NOXXON Provides Progress Update on the Expansion Arms of the Phase 1/2 GLORIA Trial With NOX-A12 in Brain Cancer Patients


Regulatory News:



NOXXON Pharma N.V. (Euronext Growth Paris: ALNOX) (Paris:ALNOX), a biotechnology company focused on improving cancer treatments by targeting the tumor microenvironment (TME)

Exscientia and Sanofi Establish Strategic Research Collaboration to Develop AI-driven Pipeline of Precision-Engineered Medicines: https://mms.businesswire.com/media/20211110005488/en/925458/5/5299324_5299274_exscientia-logo.jpg
Exscientia and Sanofi Establish Strategic Research Collaboration to Develop AI-driven Pipeline of Precision-Engineered Medicines


Sanofi and Exscientia announced today a groundbreaking research collaboration and license agreement to develop up to 15 novel small molecule candidates across oncology and immunology, leveraging

QIAGEN Strengthens Growing Portfolio of Applications for Its Digital PCR Platform QIAcuity With New Collaborations
QIAGEN Strengthens Growing Portfolio of Applications for Its Digital PCR Platform QIAcuity With New Collaborations


QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced new additions to the growing number of applications for QIAcuity, its ultrasensitive digital PCR (dPCR) platform that has set

EQS-News: Nordea Bank Abp: Flagging notification : http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24153/330px-Nordea_logo.svg.png
EQS-News: Nordea Bank Abp: Flagging notification
EQS-News: Nordea Bank Abp: Flagging notification
DGAP-News: Symrise accelerates international expansion in Pet Nutrition through acquisition of Schaffelaarbos: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23742/Symrise_Logo.svg.png
DGAP-News: Symrise accelerates international expansion in Pet Nutrition through acquisition of Schaffelaarbos
DGAP-News: Symrise accelerates international expansion in Pet Nutrition through acquisition of Schaffelaarbos
DGAP-News: MorphoSys Reports Preliminary 2021 Monjuvi U.S. Sales and Provides 2022 Financial Guidance: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24061/Morphosys-logo.svg.png
DGAP-News: MorphoSys Reports Preliminary 2021 Monjuvi U.S. Sales and Provides 2022 Financial Guidance
DGAP-News: MorphoSys Reports Preliminary 2021 Monjuvi U.S. Sales and Provides 2022 Financial Guidance
DGAP-Adhoc: MorphoSys AG Reports Preliminary 2021 Monjuvi U.S. Sales and Provides 2022 Financial Guidance: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24061/Morphosys-logo.svg.png
DGAP-Adhoc: MorphoSys AG Reports Preliminary 2021 Monjuvi U.S. Sales and Provides 2022 Financial Guidance
DGAP-Adhoc: MorphoSys AG Reports Preliminary 2021 Monjuvi U.S. Sales and Provides 2022 Financial Guidance
KKR Real Estate Finance Trust Inc. Announces Pricing of Public Offering of Additional Shares of 6.50% Series A Cumulative Redeemable Preferred Stock: https://mms.businesswire.com/media/20191216005659/en/582992/5/02_02_17_KREF_Logo_RGB_01_300.jpg
KKR Real Estate Finance Trust Inc. Announces Pricing of Public Offering of Additional Shares of 6.50% Series A Cumulative Redeemable Preferred Stock


KKR Real Estate Finance Trust Inc. (“KREF”) (NYSE: KREF) today announced the pricing of a public offering of 4,400,000 additional shares of its 6.50% Series A Cumulative Redeemable Preferred Stock

Columbia Care Announces Commencement of Noteholder Consent Solicitation to Increase Debt Capacity: https://mms.businesswire.com/media/20200203005819/en/720533/5/CC_CORPORATE_-01.jpg
Columbia Care Announces Commencement of Noteholder Consent Solicitation to Increase Debt Capacity


Columbia Care Inc. (NEO: CCHW) (CSE:CCHW) (OTCQX:CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), one of the largest and most experienced cultivators, manufacturers and providers of cannabis

Atmos Energy Corporation to Host Fiscal 2022 First Quarter Earnings Conference Call on February 9, 2022: https://mms.businesswire.com/media/20191106005730/en/11463/5/Atmos_Energy.jpg
Atmos Energy Corporation to Host Fiscal 2022 First Quarter Earnings Conference Call on February 9, 2022


Atmos Energy Corporation (NYSE: ATO) will host a conference call on Wednesday, February 9, at 9 a.m. Eastern to review the company’s Fiscal 2022 first quarter financial results. Atmos Energy will

ADTRAN Stockholders Overwhelmingly Approve Business Combination with ADVA Optical Networking SE: https://mms.businesswire.com/media/20200121005937/en/37691/5/ADTRAN_high-res.jpg
ADTRAN Stockholders Overwhelmingly Approve Business Combination with ADVA Optical Networking SE


ADTRAN, Inc., (NASDAQ: ADTN) today announced that its stockholders have approved the business combination with ADVA Optical Networking SE by an overwhelming majority. In a Special Meeting of

Xencor to Present at the H.C. Wainwright Bioconnect Virtual Conference: https://mms.businesswire.com/media/20191105006084/en/713581/5/Xencor_RGB_fullcolor.jpg
Xencor to Present at the H.C. Wainwright Bioconnect Virtual Conference


Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune diseases, today announced